Improving outcomes with ICIs in advanced or recurrent endometrial cancer
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss improving outcomes with immune checkpoint inhibitors in advanced or recurrent endometrial cancer.
The multidisciplinary team:
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is provided by touchIME.
For further information visit our website:
It is Free